The Israeli Channel 12 said Monday that the Mossad intelligence agency had brought in a few weeks ago the Chinese vaccine against the Covid-19 virus for the purpose of the Israeli Biological Institute for its studies.
The Mossad has been involved in the management of the Corona epidemic crisis in Tel Aviv since the beginning of the pandemic, by working to provide artificial respirators and various accessories related to combating the epidemic and providing treatment for the injured.
Media reported that the severity and rapidity of the epidemic, in light of global geopolitical tension between international and regional powers, prompted a frantic global race to create or obtain a vaccine, which led to the involvement of its intelligence agencies in acts of spying on vaccine projects, including cyber attacks Which targeted laboratories and pharmaceutical companies.
For its part, the Israeli newspaper “Jerusalem Post” added, according to one of its sources in the Ministry of Health, that Tel Aviv is seeking to reach agreements to purchase anti-Coronavirus vaccines from various sources. It quoted this source in the ministry as saying that “there are many diplomatic efforts being exerted behind the scenes,” adding, “We are doing everything to ensure that Israeli citizens will have a vaccine available as soon as possible.”
And the Israeli Institute for Biological Research announced yesterday, Sunday, that it will start human trials next week for a vaccine against the emerging corona virus, “Brilife”. And confirms, “Jerusalem Post” that this vaccine has obtained the necessary licenses from the Ministry of Health and the “Helsinki Committee” to start testing on humans.
Source: Israeli media.
These were the details of the news Report: “Mossad” brought the Chinese vaccine against Corona for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at eg24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.